Locally Advanced Basal Cell Carcinoma

Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Philogen
PhilogenItaly - Monteriggioni
2 programs
2
L19IL2Phase 21 trial
L19IL2/L19TNFPhase 21 trial
Active Trials
NCT07227350Not Yet Recruiting180Est. Feb 2031
NCT07227870Not Yet Recruiting92Est. Feb 2031
Genentech
GenentechCA - Oceanside
1 program
1
VismodegibPhase 21 trial
Active Trials
NCT01835626Completed24Est. Sep 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
PhilogenL19IL2/L19TNF
PhilogenL19IL2
GenentechVismodegib

Clinical Trials (3)

Total enrollment: 296 patients across 3 trials

NCT07227870PhilogenL19IL2/L19TNF

L19IL2/TNF in Patients With Basal Cell Carcinoma

Start: Feb 2026Est. completion: Feb 203192 patients
Phase 2Not Yet Recruiting

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Start: Feb 2026Est. completion: Feb 2031180 patients
Phase 2Not Yet Recruiting

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Start: May 2013Est. completion: Sep 201924 patients
Phase 2Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space